Bluejay Diagnostics Hits Key Manufacturing Milestone with Toray

Bluejay Diagnostics, Inc. (NASDAQ:BJDX), a medical diagnostics company, announced the successful establishment of a manufacturing site for its Symphony™ cartridges. This achievement marks a crucial step in the company's path toward regulatory submission and potential commercialization.

The milestone was reached ahead of schedule, as stipulated by the company's amended license agreement with Toray Industries, Inc. Bluejay's manufacturing strategy includes facilities at SanyoSeiko Co., Ltd. in Japan and ALURIS Sciences in the U.S. This dual approach aims to enhance supply-chain resilience and operational flexibility.

This progress reduces business risk as Bluejay moves toward commercial readiness. The company plans to advance its manufacturing scale-up alongside regulatory preparations for the Symphony™ IL-6 Test, designed to assist sepsis triage and requires FDA approval.